Ad is loading...
CNWIX
Price
$19.38
Change
-$0.19 (-0.97%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

CNWIX vs RNWFX

Header iconCNWIX vs RNWFX Comparison
Open Charts CNWIX vs RNWFXBanner chart's image
Calamos Evolving World Growth I
Price$19.38
Change-$0.19 (-0.97%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
CNWIX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNWIX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNWIX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. CNWIX (388M). RNWFX pays higher dividends than CNWIX: RNWFX (1.51) vs CNWIX (0.50). CNWIX was incepted earlier than RNWFX: CNWIX (16 years) vs RNWFX (23 years). CNWIX is a more actively managed with annual turnover of: 137.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than CNWIX: RNWFX (250) vs CNWIX (1000000). CNWIX annual gain was more profitable for investors over the last year : 21.64 vs. RNWFX (11.54). CNWIX return over 5 years is better than : 37.37 vs. RNWFX (17.17).
CNWIXRNWFXCNWIX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD15.7017.099221%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets388M60.9B1%
Annual Yield % from dividends0.501.5133%
Returns for 1 year21.6411.54187%
Returns for 3 years-13.78-14.5595%
Returns for 5 years37.3717.17218%
Returns for 10 years46.6141.00114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics